Personal profile
Research areas
Clinical research in diabetic complications, main focus on diabetic nephropathy and cardiovascular disease
clinical trials, biomarker discovery with targeted and untargeted methods
metabolomics in relation to progresion of type 1 and type 2 diabetes, liver disease and diabetic complications
Main research areas
Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics
Current research
Focus on late diabetic complications,
biomarkers predicting risk for initiation or progression of complications,
clinical studies of interventions aiming at preventing or treating complications
improving understanding of pathophysiology of complications
Potential conflicts of interest
External positions
board member, Bagger Sørensen Fonden
2024 → …
member(chair (2024+2025)), Sundhed og Sygdom, Det Frie Forskningsråd
2021 → …
Steno Diabetes Center A/S
… → 2016
Professor in endocrinology with focus on vascular complications, University of Copenhagen
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Research output
-
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone
Agarwal, R., Correa-Rotter, R., Navaneethan, S. D., Fukami, K., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Mottl, A. K., Nangaku, M., Rosenstock, J., Rossing, P., Vaduganathan, M., Scott, C., Li, L., Aldworth, C., Green, J. B. & Weir, M. R., 29 Mar 2026, (E-pub ahead of print) In: Journal of the American Society of Nephrology.Research output: Contribution to journal › Journal article › Research › peer-review
-
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD
Singh, A. K., Anker, S. D., Pitt, B., Rossing, P., Ruilope, L. M., Ahlers, C., Farag, Y. M. K., Lambelet, M., Brinker, M. D., Rohwedder, K., Filippatos, G. & FIDELIO‐DKD and FIGARO‐DKD investigators, Mar 2026, In: Kidney International Reports. 11, 3, 103704.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis
Heerspink, H. J. L., Little, D. J., Gasparyan, S. B., Chertow, G. M., Toto, R. D., Rossing, P., Correa-Rotter, R., Sjostrom, C. D., Wheeler, D. C. & Jongs, N., 26 Jan 2026, (E-pub ahead of print) In: Clinical journal of the American Society of Nephrology : CJASN.Research output: Contribution to journal › Journal article › Research › peer-review
-
Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular Ultrasound
Ferreira-Divino, L. F., Poulsen, C. G., Rotbain Curovic, V., Urbak, L., Collet-Billon, A., Rouet, L., Frimodt-Møller, M., Eldrup, N., Hansen, T. W., Sillesen, H. & Rossing, P., 30 Mar 2026, (E-pub ahead of print) In: Diabetes, Obesity and Metabolism.Research output: Contribution to journal › Journal article › Research › peer-review
-
Association Between Off-Label Use of Cardio-Kidney-Metabolic Therapies and Risk of Cardiovascular Events in Type 1 Diabetes: A Real-World Evidence Study
Pandey, A., Repetto, E., Perkins, C., Rossing, P. & Caramori, M. L., 9 Mar 2026, (E-pub ahead of print) In: Diabetes, Obesity and Metabolism. p. 4352-4355 4 p.Research output: Contribution to journal › Letter › peer-review
1 Citation (Scopus)
Prizes
-
-
-
Dandy foundation honorary award
Rossing, P. (Recipient), 2000
Prize: Prizes, scholarships, distinctions
-
-
Novartis Young Investigator Award
Rossing, P. (Recipient), 2008
Prize: Prizes, scholarships, distinctions
Activities
-
-
-
SGLT2 inhibition and Finerenone in Diabetic Kidney Disease
medicine, D. (Lecturer)
4 Dec 2023Activity: Talk or presentation › Lecture and oral contribution
-
Precision Medicine in Diabetes Complications
Rossing, P. (Lecturer)
30 Nov 2023Activity: Talk or presentation › Lecture and oral contribution
-